Multi‐Channel Lanthanide Nanocomposites for Customized Synergistic Treatment of Orthotopic Multi‐Tumor Cases

Simultaneous photothermal ablation of multiple tumors is limited by unpredictable photo‐induced apoptosis, caused by individual intratumoral differences. Here, a multi‐channel lanthanide nanocomposite was used to achieve tailored synergistic treatment of multiple subcutaneous orthotopic tumors under non‐uniform whole‐body infrared irradiation prescription. The nanocomposite reduces intratumoral glutathione by simultaneously activating the fluorescence and photothermal channels. The fluorescence provides individual information on different tumors, allowing customized prescriptions to be made. This enables optimal induction of hyperthermia and dosage of chemo drugs, to ensure treatment efficacy, while avoiding overtherapy. With an accessional therapeutic laser system, customized synergistic treatment of subcutaneous orthotopic cancer cases with multiple tumors is possible with both high efficacy and minimized side effects. By using a multichannel lanthanide‐based nanocomposite, the tumor ablation efficiency can be predicted through fluorescence imaging for customized synergistic ablation of multiple orthotopic breast tumors simultaneously under a non‐uniform light field. With a customized irradiation prescription, it shows better therapeutic efficiency and recovery rate than traditional therapeutic methods.